Literature DB >> 26166824

NVL2, a nucleolar AAA-ATPase, is associated with the nuclear exosome and is involved in pre-rRNA processing.

Yuki Yoshikatsu1, Yo-ichi Ishida2, Haruka Sudo2, Keizo Yuasa1, Akihiko Tsuji1, Masami Nagahama3.   

Abstract

Nuclear VCP-like 2 (NVL2) is a member of the chaperone-like AAA-ATPase family and is involved in the biosynthesis of 60S ribosomal subunits in mammalian cells. We previously showed the interaction of NVL2 with a DExD/H-box RNA helicase MTR4/DOB1, which is a known cofactor for an exoribonuclease complex, the exosome. This finding implicated NVL2 in RNA metabolic processes during ribosome biogenesis. In the present study, we found that a series of mutations within the ATPase domain of NVL2 causes a defect in pre-rRNA processing into mature 28S and 5.8S rRNAs. Co-immunoprecipitation analysis showed that NVL2 was associated with the nuclear exosome complex, which includes RRP6 as a nucleus-specific catalytic subunit. This interaction was prevented by depleting either MTR4 or RRP6, indicating their essential role in mediating this interaction with NVL2. Additionally, knockdown of MPP6, another cofactor for the nuclear exosome, also prevented the interaction by causing MTR4 to dissociate from the nuclear exosome. These results suggest that NVL2 is involved in pre-rRNA processing by associating with the nuclear exosome complex and that MPP6 is required for maintaining the integrity of this rRNA processing complex.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  AAA-ATPase; NVL2; Pre-rRNA processing; RNA exosome; Ribosome biogenesis

Mesh:

Substances:

Year:  2015        PMID: 26166824     DOI: 10.1016/j.bbrc.2015.07.032

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  9 in total

Review 1.  Principles of 60S ribosomal subunit assembly emerging from recent studies in yeast.

Authors:  Salini Konikkat; John L Woolford
Journal:  Biochem J       Date:  2017-01-15       Impact factor: 3.857

2.  WDR74 modulates melanoma tumorigenesis and metastasis through the RPL5-MDM2-p53 pathway.

Authors:  Yumei Li; Yu Zhou; Bifei Li; Fan Chen; Weiyu Shen; Yusheng Lu; Chunlian Zhong; Chen Zhang; Huanzhang Xie; Vladimir L Katanaev; Lee Jia
Journal:  Oncogene       Date:  2020-01-31       Impact factor: 9.867

3.  Structural Analysis Reveals Features of Ribosome Assembly Factor Nsa1/WDR74 Important for Localization and Interaction with Rix7/NVL2.

Authors:  Yu-Hua Lo; Erin M Romes; Monica C Pillon; Mack Sobhany; Robin E Stanley
Journal:  Structure       Date:  2017-04-13       Impact factor: 5.006

4.  Psychomotor retardation with a 1q42.11-q42.12 deletion.

Authors:  Jialing He; Yingjun Xie; Shu Kong; Wenjun Qiu; Xiaoman Wang; Ding Wang; Xiaofang Sun; Deming Sun
Journal:  Hereditas       Date:  2017-03-06       Impact factor: 3.271

5.  RNA surveillance by the nuclear RNA exosome: mechanisms and significance.

Authors:  Koichi Ogami; Yaqiong Chen; James L Manley
Journal:  Noncoding RNA       Date:  2018-03-11

Review 6.  Uncovering the assembly pathway of human ribosomes and its emerging links to disease.

Authors:  Katherine E Bohnsack; Markus T Bohnsack
Journal:  EMBO J       Date:  2019-05-14       Impact factor: 11.598

Review 7.  Shaping the Nascent Ribosome: AAA-ATPases in Eukaryotic Ribosome Biogenesis.

Authors:  Michael Prattes; Yu-Hua Lo; Helmut Bergler; Robin E Stanley
Journal:  Biomolecules       Date:  2019-11-07

8.  MPP6 stimulates both RRP6 and DIS3 to degrade a specified subset of MTR4-sensitive substrates in the human nucleus.

Authors:  Naoko Fujiwara; Maki Shigemoto; Mizuki Hirayama; Ken-Ichi Fujita; Shigeto Seno; Hideo Matsuda; Masami Nagahama; Seiji Masuda
Journal:  Nucleic Acids Res       Date:  2022-08-26       Impact factor: 19.160

9.  Cryo-EM structure of the essential ribosome assembly AAA-ATPase Rix7.

Authors:  Yu-Hua Lo; Mack Sobhany; Allen L Hsu; Brittany L Ford; Juno M Krahn; Mario J Borgnia; Robin E Stanley
Journal:  Nat Commun       Date:  2019-01-31       Impact factor: 14.919

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.